| Authors: |
Füssl F; NIBRT - The National Institute for Bioprocessing Research and Training, Foster Avenue, Mount Merrion, Blackrock, Co. Dublin, A94 X099, Ireland., Barry CS; Spirogen, a Member of the AstraZeneca Group, QMB Innovation Centre, 42 New Road, London, E1 2AX, United Kingdom., Pugh KM; Spirogen, a Member of the AstraZeneca Group, QMB Innovation Centre, 42 New Road, London, E1 2AX, United Kingdom., Chooi KP; Spirogen, a Member of the AstraZeneca Group, QMB Innovation Centre, 42 New Road, London, E1 2AX, United Kingdom., Vijayakrishnan B; Spirogen, a Member of the AstraZeneca Group, QMB Innovation Centre, 42 New Road, London, E1 2AX, United Kingdom., Kang GD; Spirogen, a Member of the AstraZeneca Group, QMB Innovation Centre, 42 New Road, London, E1 2AX, United Kingdom., von Bulow C; Spirogen, a Member of the AstraZeneca Group, QMB Innovation Centre, 42 New Road, London, E1 2AX, United Kingdom., Howard PW; Spirogen, a Member of the AstraZeneca Group, QMB Innovation Centre, 42 New Road, London, E1 2AX, United Kingdom., Bones J; NIBRT - The National Institute for Bioprocessing Research and Training, Foster Avenue, Mount Merrion, Blackrock, Co. Dublin, A94 X099, Ireland; School of Chemical and Bioprocess Engineering, University College Dublin, Belfield, Dublin, D04 V1W8, Ireland. Electronic address: jonathan.bones@nibrt.ie. |